DOI:
10.1055/s-00035026
Applied Clinical Informatics
LinksClose Window
References
Shea KM, Hobbs ALV, Jaso TC. , et al.
Effect of a health care system respiratory fluoroquinolone restriction program to alter utilization and impact rates of clostridium difficile infection.
Antimicrob Agents Chemother 2017;
61 (06) e00125-17
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.